rs2796814

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003238.6(TGFB2):​c.347-16930C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.325 in 152,134 control chromosomes in the GnomAD database, including 9,812 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 9812 hom., cov: 32)

Consequence

TGFB2
NM_003238.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.100

Publications

8 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.555 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFB2NM_003238.6 linkc.347-16930C>G intron_variant Intron 1 of 6 ENST00000366930.9 NP_003229.1
TGFB2NM_001135599.4 linkc.431-16930C>G intron_variant Intron 2 of 7 NP_001129071.1
TGFB2NR_138148.2 linkn.1713-16930C>G intron_variant Intron 1 of 6
TGFB2NR_138149.2 linkn.1797-16930C>G intron_variant Intron 2 of 7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFB2ENST00000366930.9 linkc.347-16930C>G intron_variant Intron 1 of 6 1 NM_003238.6 ENSP00000355897.4
TGFB2ENST00000366929.4 linkc.431-16930C>G intron_variant Intron 2 of 7 1 ENSP00000355896.4
TGFB2ENST00000488793.1 linkn.11-16930C>G intron_variant Intron 1 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.325
AC:
49404
AN:
152016
Hom.:
9780
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.560
Gnomad AMI
AF:
0.137
Gnomad AMR
AF:
0.291
Gnomad ASJ
AF:
0.249
Gnomad EAS
AF:
0.373
Gnomad SAS
AF:
0.210
Gnomad FIN
AF:
0.163
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.225
Gnomad OTH
AF:
0.324
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.325
AC:
49493
AN:
152134
Hom.:
9812
Cov.:
32
AF XY:
0.320
AC XY:
23789
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.561
AC:
23278
AN:
41496
American (AMR)
AF:
0.292
AC:
4460
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.249
AC:
865
AN:
3472
East Asian (EAS)
AF:
0.374
AC:
1923
AN:
5146
South Asian (SAS)
AF:
0.209
AC:
1007
AN:
4824
European-Finnish (FIN)
AF:
0.163
AC:
1730
AN:
10582
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.225
AC:
15334
AN:
68006
Other (OTH)
AF:
0.322
AC:
681
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1538
3077
4615
6154
7692
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.278
Hom.:
907
Bravo
AF:
0.349
Asia WGS
AF:
0.325
AC:
1130
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
1.4
DANN
Benign
0.34
PhyloP100
0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2796814; hg19: chr1-218561581; COSMIC: COSV65108703; API